Gyu Seong Heo
Overview
Explore the profile of Gyu Seong Heo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
583
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Terada Y, Li W, Amrute J, Bery A, Liu C, Nunna V, et al.
Cell Rep
. 2025 Mar;
44(3):115380.
PMID: 40042972
Triggering receptor expressed on myeloid cells 1 (TREM-1) has been shown to amplify inflammatory signals, such as Toll-like receptor signaling, after infection and sterile injury. While previous studies have demonstrated...
2.
Yang B, Chan M, Heo G, Lou L, Luehmann H, Park C, et al.
JHEP Rep
. 2024 Dec;
6(12):101220.
PMID: 39624233
Background & Aims: Metabolic-dysfunction associated steatohepatitis (MASH) is associated with obesity and diabetes, and is linked to liver fibrosis and cardiovascular disease. Identification of patients who have MASH is challenging...
3.
Farooq H, Luehmann H, Koenitzer J, Heo G, Sultan D, Kulkarni D, et al.
EBioMedicine
. 2024 Nov;
110:105431.
PMID: 39515027
Background: Pulmonary fibrosis is a challenging clinical problem with lung pathology featuring immune cell infiltrates, fibroblast expansion, and matrix deposition. Molecular analysis of diseased lungs and preclinical models have uncovered...
4.
Amrute J, Luo X, Penna V, Yang S, Yamawaki T, Hayat S, et al.
Nature
. 2024 Oct;
635(8038):423-433.
PMID: 39443792
Inflammation and tissue fibrosis co-exist and are causally linked to organ dysfunction. However, the molecular mechanisms driving immune-fibroblast cell communication in human cardiac disease remain unexplored and there are at...
5.
Gallerand A, Dolfi B, Stunault M, Caillot Z, Castiglione A, Strazzulla A, et al.
Nat Commun
. 2024 Oct;
15(1):9027.
PMID: 39424804
Monocytes directly contribute to atherosclerosis development by their recruitment to plaques in which they differentiate into macrophages. In the present study, we ask how modulating monocyte glucose metabolism could affect...
6.
Lou L, Detering L, Luehmann H, Amrute J, Sultan D, Ma P, et al.
Circ Res
. 2024 Sep;
135(10):990-1003.
PMID: 39328090
Background: Immune checkpoint inhibitor (ICI) usage has resulted in immune-related adverse events in patients with cancer, such as accelerated atherosclerosis. Of immune cells involved in atherosclerosis, the role of CCR2+...
7.
Lavine K, Sultan D, Luehmann H, Detering L, Zhang X, Heo G, et al.
Nat Cardiovasc Res
. 2024 Jul;
2(10):874-880.
PMID: 38947883
Among the diverse populations of myeloid cells that reside within the healthy and diseased heart, C-C chemokine receptor 2 (CCR2) is specifically expressed on inflammatory populations of monocytes and macrophages...
8.
Hou J, Chen Y, Cai Z, Heo G, Yuede C, Wang Z, et al.
Sci Transl Med
. 2024 Apr;
16(741):eadj9052.
PMID: 38569016
Microglia help limit the progression of Alzheimer's disease (AD) by constraining amyloid-β (Aβ) pathology, effected through a balance of activating and inhibitory intracellular signals delivered by distinct cell surface receptors....
9.
Zhang X, Heo G, Li A, Lahad D, Detering L, Tao J, et al.
J Nucl Med
. 2024 Mar;
65(5):775-780.
PMID: 38548349
Tissue-resident macrophages are complementary to proinflammatory macrophages to promote the progression of atherosclerosis. The noninvasive detection of their presence and dynamic variation will be important to the understanding of their...
10.
Zhang X, Qiu L, Sultan D, Luehmann H, Yu Y, Zhang X, et al.
Nucl Med Biol
. 2024 Feb;
130-131:108893.
PMID: 38422918
Atherosclerosis is a chronic inflammatory disease and the leading cause of morbidity and mortality worldwide. CC motif chemokine ligand 2 and its corresponding cognate receptor 2 (CCL2/CCR2) signaling has been...